Items where Author is "Hamad, I."
Group by: Item Type | No Grouping
Number of items: 6.
Hamad, I., Al-Hanbali, O., Hunter, A.C., Rutt, K.J., Andresen, T.L. and Moghimi, S.M. (2010) Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere−serum interface: implications for stealth nanoparticle engineering ACS Nano, 4 (11). pp. 6629-6638. ISSN 1936-0851
Moghimi, S.M., Anderson, A.J., Hashemi, S.H., Lettiero, B., Ahmadvand, D., Hunter, A.C., Andresen, T.L, Hamad, I. and Szebeni, J. (2010) Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead Journal of Controlled Release, 146 (2). pp. 175-181. ISSN 0168-3659
Hamad, I., Hunter, A.C., Rutt, K.J., Liu, Z., Dai, H. and Moghimi, S.M. (2008) Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover Molecular Immunology, 45 (14). pp. 3797-3803. ISSN 0161-5890
Hamad, I. (2008) The molecular basis of complement activation by model nanomedicines. Doctoral thesis, University of Brighton.
Hamad, I., Hunter, A.C., Szebeni, J. and Moghimi, S.M. (2008) Poly(ethylene glycol)s trigger complement activation in human serum through alternative and lectin pathways: a plausible cause for anaphylaxis Molecular Immunology, 46 (2). pp. 225-232. ISSN 0161-5890
Moghimi, S.M., Hamad, I., Bunger, R., Andresen, T.L., Jorgensen, K., Hunter, A.C., Rosivall, L., Baranji, L. and Szebeni, J. (2006) Activation of the Human Complement System by cholesterol-rich and PEGylated liposomes- Modulation of cholesterol-rich liposome-mediated complement activation by elevated serum LDL and HDL levels Journal of Liposome Research, 16. pp. 167-174. ISSN 0898-2104